Evaluation of the efficacy of rezafungin, a novel echinocandin, in the treatment of disseminated Candida auris infection using an immunocompromised mouse model

BACKGROUND: Multiple cases of Candida auris infection have been reported with high mortality rates owing to its MDR nature. Rezafungin (previously CD101) is a novel echinocandin with enhanced stability and pharmacokinetics that achieves high plasma drug exposure and allows for once weekly dose admin...

Descripción completa

Detalles Bibliográficos
Autores principales: Hager, Christopher L, Larkin, Emily L, Long, Lisa A, Ghannoum, Mahmoud A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6070025/
https://www.ncbi.nlm.nih.gov/pubmed/29897469
http://dx.doi.org/10.1093/jac/dky153

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6070025/
https://www.ncbi.nlm.nih.gov/pubmed/29897469
http://dx.doi.org/10.1093/jac/dky153

Ejemplares similares